Biocardia Lifesciences
San Carlos, US · Delaware corporation
Find your way into Biocardia Lifesciences
Sign up to see every warm intro you have to Biocardia Lifesciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biocardia Lifesciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DM

DAVID MCCLUNGExecutiveDavid McClung is an executive officer at Biocardia Lifesciences with background in finance spanning both private industry and public accounting roles across publicly and privately financed organizations.
PA

PETER ALTMANExecutivePeter Altman is an experienced executive in biotechnology, medical devices, and diagnostics with expertise in financing, regulatory strategy, clinical development, and licensing. He currently serves as an executive officer and director at Biocardia Lifesciences.
Reported raises · per SEC filings
Form D private placements$8.7M disclosed across 2 rounds · 2016
▶$4.4MraisedNov 2016 · 18 investors · Other Health CareRule 506(b)
▶$4.4MraisedNov 2016 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- DAVID MCCLUNGExecutive Officer
- PETER ALTMANExecutive Officer, Director, Promoter
- Offering amount
- $6.5M
- Amount sold
- $4.4M
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.4MraisedNov 2016 · 18 investors · Other Health CareRule 506(b)
▶$4.4MraisedNov 2016 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- DAVID MCCLUNGExecutive Officer
- PETER ALTMANExecutive Officer, Director, Promoter
- Offering amount
- $6.5M
- Amount sold
- $4.4M
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Biocardia Lifesciences raised?
- Biocardia Lifesciences has disclosed $8.7M raised across 2 rounds.
- Where is Biocardia Lifesciences headquartered?
- Biocardia Lifesciences is headquartered in San Carlos, US.